Charles E. Richardson - 28 Jul 2021 Form 3 Insider Report for Icosavax, Inc.

Signature
/s/ Thomas Russo, Attorney-in Fact
Issuer symbol
N/A
Transactions as of
28 Jul 2021
Net transactions value
$0
Form type
3
Filing time
28 Jul 2021, 21:19:58 UTC
Next filing
02 Aug 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ICVX Common Stock 51,133 28 Jul 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ICVX Stock Option (Right to Buy) 28 Jul 2021 Common Stock 109,864 $0.8300 Direct F2
holding ICVX Stock Option (Right to Buy) 28 Jul 2021 Common Stock 22,843 $1.04 Direct F3
holding ICVX Stock Option (Right to Buy) 28 Jul 2021 Common Stock 113,097 $5.90 Direct F4
holding ICVX Stock Option (Right to Buy) 28 Jul 2021 Common Stock 83,250 $15.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 8,198 shares subject to repurchase by us, which are subject to vesting.
F2 25% of the shares subject to the option vested on 9/13/2020, and 1/48th of the shares subject to the option vest monthly thereafter.
F3 25% of the shares subject to the option will vest on 1/29/2022, and 1/48th of the shares subject to the option vest monthly thereafter.
F4 25% of the shares subject to the option will vest on 3/19/2022, and 1/48th of the shares subject to the option vest monthly thereafter.
F5 1/48th of the shares subject to the option vest monthly.

Remarks:

Senior Vice President, Technical Operations Exhibit List: Exhibit 24 - Power of Attorney